To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01479244
Title Efficacy and Safety Study of NeuVax (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence
Acronym PRESENT
Recruitment Completed
Gender female
Phase Phase III
Variant Requirements No
Sponsors Galena Biopharma, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA | ROU | POL | ISR | HUN | GBR | FRA | DEU | CAN | BGR


No variant requirements are available.